Stéphane Giraudier

Mermayde — Norway

Medicine · Health Sciences

44h-index6.3kcitations205works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment(113), Chronic Myeloid Leukemia Treatments(70), Eosinophilic Disorders and Syndromes(68), Acute Myeloid Leukemia Research(43), Kruppel-like factors research(36)

Publications204 total

Hematopoiesis as a continuum: from stochastic compartmental model to hydrodynamic limit
arXiv (Cornell University)·2026Open Access
Hematopoiesis as a continuum: from stochastic compartmental model to hydrodynamic limit
ArXiv.org·2026Open Access
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Nature Communications·2025· 3 citedOpen Access
FOXP1 contributes to murine hematopoietic stem cell functionality
Experimental Hematology·2025Open Access
Classical Myelo-Proliferative Neoplasms emergence and development based on real life incidence and mathematical modeling
2025Open Access
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera
Leukemia·2025· 7 citedOpen Access
<i>SH2B3 L</i>oss of Function Variants Are Potential Drivers of Severe Thrombocytosis
Blood·2024· 1 cited
Clonal evolution: a landmark of MPN evolution
Frontiers in Hematology·2024Open Access
<scp>JAK2V617F</scp>‐dependent down regulation of <scp>SHP</scp>‐1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of <scp>TGF</scp>‐β
Journal of Cellular and Molecular Medicine·2024· 3 citedOpen Access
Classical JAK2V617F+ Myeloproliferative Neoplasms emergence and development based on real life incidence and mathematical modeling
arXiv (Cornell University)·2024Open Access
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
Leukemia·2024· 8 citedOpen Access
Association of <scp><i>MPL</i> K39N</scp> and <scp>R102P</scp> heterozygous germline mutations lead to hereditary thrombocytosis
American Journal of Hematology·2024Open Access
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs
Haematologica·2024· 5 citedOpen Access
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of <scp>MIPSS70</scp>+ v2.0 over <scp>MYSEC‐PM</scp>
American Journal of Hematology·2024· 10 citedOpen Access
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms
Blood Cancer Journal·2024· 11 citedOpen Access
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Leukemia·2023· 26 cited
Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera
Blood·2023· 18 cited
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)
Leukemia·2023· 4 cited
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms
2023Open Access
POS0954 CLINICAL FEATURES AND GENOMIC LANDSCAPE OF MYELOPROLIFERATIVE NEOPLASM (MPN) PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASES
Annals of the Rheumatic Diseases·2023Open Access
page 1 of 11Next →

Frequent Co-authors

William Vainchenker(17), Jean‐Jacques Kiladjian(10), Bruno Cassinat(10), Pierre Fenaux(7), Philippe Rousselot(7), Laurence Legros(7), Carole Tonetti(6), Michel Tulliez(6), Emmanuelle Verger(6), Stefan N. Constantinescu(6), Lydia Roy(5), Martine Gardembas(5), Nicole Casadevall(4), Jean‐Luc Villeval(4), M Tulliez(4), Jean‐Christophe Ianotto(4), Christine Chomienne(4), Franck E. Nicolini(4), Nabih Maslah(4), C. Pecquet(4)